These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35221021)
61. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196 [TBL] [Abstract][Full Text] [Related]
62. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia. Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D; Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496 [TBL] [Abstract][Full Text] [Related]
63. Role of quetiapine in protection of neurodegeneration after traumatic brain injury. Morra JA; Alao AO Int J Psychiatry Med; 2020 Mar; 55(2):67-73. PubMed ID: 30913942 [TBL] [Abstract][Full Text] [Related]
64. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. Newcomer JW; Ratner RE; Eriksson JW; Emsley R; Meulien D; Miller F; Leonova-Edlund J; Leong RW; Brecher M J Clin Psychiatry; 2009 Apr; 70(4):487-99. PubMed ID: 19358783 [TBL] [Abstract][Full Text] [Related]
65. Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy. Ajayi OO; Holroyd S BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197846 [TBL] [Abstract][Full Text] [Related]
66. Quetiapine: a review of its safety in the management of schizophrenia. Dev V; Raniwalla J Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217 [TBL] [Abstract][Full Text] [Related]
67. Quetiapine: efficacy and tolerability in schizophrenia. Kasper S; Tauscher J; Heiden A Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888 [TBL] [Abstract][Full Text] [Related]
68. Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. Glick ID; Marder SR J Clin Psychiatry; 2005 May; 66(5):638-41. PubMed ID: 15889952 [TBL] [Abstract][Full Text] [Related]
69. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. Hayes JF; Marston L; Walters K; Geddes JR; King M; Osborn DP PLoS Med; 2016 Aug; 13(8):e1002058. PubMed ID: 27483368 [TBL] [Abstract][Full Text] [Related]
70. Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial. Pae CU; Kim JJ; Lee CU; Lee SJ; Lee C; Patkar AA; Masand PS; Paik IH J Clin Psychiatry; 2007 Mar; 68(3):399-405. PubMed ID: 17388709 [TBL] [Abstract][Full Text] [Related]
71. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951 [TBL] [Abstract][Full Text] [Related]
72. Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study. Li Y; Li H; Liu Y; Yan X; Yue Y; Qian M Curr Med Res Opin; 2012 Oct; 28(10):1725-32. PubMed ID: 22978771 [TBL] [Abstract][Full Text] [Related]
73. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia. Kasper S; Brecher M; Fitton L; Jones AM Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701 [TBL] [Abstract][Full Text] [Related]
74. Leukopenia and neutropenia induced by quetiapine. Cowan C; Oakley C Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):292-4. PubMed ID: 16930797 [TBL] [Abstract][Full Text] [Related]
75. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657 [TBL] [Abstract][Full Text] [Related]
76. Long-Term use of quetiapine in elderly patients with psychotic disorders. Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905 [TBL] [Abstract][Full Text] [Related]
77. Incidence of Neutropenia With Valproate and Quetiapine Combination Treatment in Subjects With Acquired Brain Injuries. Park HJ; Kim JY Arch Phys Med Rehabil; 2016 Feb; 97(2):183-8. PubMed ID: 26427579 [TBL] [Abstract][Full Text] [Related]
78. Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis. Locklear JC; Wahlqvist P; Gustafsson U; Udd M; Fajutrao L; Eriksson H J Comp Eff Res; 2014 Jul; 3(4):335-44. PubMed ID: 25275231 [TBL] [Abstract][Full Text] [Related]
79. Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis. Good KP; Kiss I; Buiteman C; Woodley H; Rui Q; Whitehorn D; Kopala L Br J Psychiatry Suppl; 2002 Sep; 43():s45-9. PubMed ID: 12271800 [TBL] [Abstract][Full Text] [Related]
80. Clinical experience with quetiapine in elderly patients with psychotic disorders. Madhusoodanan S; Brenner R; Alcantra A J Geriatr Psychiatry Neurol; 2000; 13(1):28-32. PubMed ID: 10753004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]